Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
Saturday, February 07, 2015 9:01:04 AM
Musclepharm lacks own manufacturing and that separates it from Dymatize in terms of cost structure. Just don't forget that it took Dymatize 20 years to reach the sales that Musclepharm got in 4 years.
So, what's best for investors? To grow organically and to focus on manufacturing that takes 20 years to get somewhere....or alternatively to focus on sales and innovative branding and get somewhere in like 5-6 years?
Most companies' problem is sales, they got the good product and the low costs....but they got a hard time selling their products.
Apple is much less involved in the manufacturing of it's products than Samsung or Sony, yet Apple sells more.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM